Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

The Role of Nucleotide Oligomerization Domain (NOD) Receptors 1 and 2 in Inflammation-Mediated Cancer Metastasis

EF 2012-13

Résumé
Despite advances in cancer care, surgery remains the cornerstone of curative treatment for most malignancies. Even in apparently early stage disease, a significant proportion of patients undergoing surgery ultimately succumb from cancer recurrence in the form of distant metastasis. A growing body of evidence links metastasis and inflammation. Cancer is an inflammatory condition and the available treatments are associated with an acute inflammatory state, be it through tissue trauma, infectious complications, or tumor-mediated inflammation. Infection-models of cancer metastasis demonstrated that the stimulation of what is called the TLR4 receptor, by the bacterial molecule, LPS, increased metastatic capacity of cancer cells. However, experimental models with congenital absence of TLR4 showed only partial reduction in cancer metastatic potential. This suggests the presence of alternative methods by which the bacterial molecule can stimulate cancer cells. Nucleotide oligomerization domain receptors 1 and 2 (NOD) could be potential targets of investigation. Based on current research, we understand NODs as important proteins that play important roles in our immune system, and their abnormal expressions have been implicated in cancer and autoimmune diseases. Thus, an understanding of how NOD receptors may participate in the inflammation- or infection-mediated metastatic cascade could ultimately provide new insight for managing cancer with a curative intent.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
281270
Name
Jiang Henry Y
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
The Role of Nucleotide Oligomerization Domain (NOD) Receptors 1 and 2 in Inflammation-Mediated Cancer Metastasis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Metastasis; Cell Adhesion Molecules; Cell Invasion/Migration; Esophageal Cancer; Infection And Metastasis; Lung Cancer; Neutrophils; Nod-Like Receptors; Surgical Complications; Toll-Like Receptors
Abstract
Despite advances in cancer care, surgery remains the cornerstone of curative treatment for most malignancies. Even in apparently early stage disease, a significant proportion of patients undergoing surgery ultimately succumb from cancer recurrence in the form of distant metastasis. A growing body of evidence links metastasis and inflammation. Cancer is an inflammatory condition and the available treatments are associated with an acute inflammatory state, be it through tissue trauma, infectious complications, or tumor-mediated inflammation. Infection-models of cancer metastasis demonstrated that the stimulation of what is called the TLR4 receptor, by the bacterial molecule, LPS, increased metastatic capacity of cancer cells. However, experimental models with congenital absence of TLR4 showed only partial reduction in cancer metastatic potential. This suggests the presence of alternative methods by which the bacterial molecule can stimulate cancer cells. Nucleotide oligomerization domain receptors 1 and 2 (NOD) could be potential targets of investigation. Based on current research, we understand NODs as important proteins that play important roles in our immune system, and their abnormal expressions have been implicated in cancer and autoimmune diseases. Thus, an understanding of how NOD receptors may participate in the inflammation- or infection-mediated metastatic cascade could ultimately provide new insight for managing cancer with a curative intent.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jiang, Henry Y
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~